- £1.72bn
- £2.90bn
- £198.20m
- 54
- 49
- 86
- 71
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21.6 | 38.5 | 42.8 | 58.5 | 198 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -15.7 | -39.9 | -2.4 | -110 | 427 |
Operating Profit | 37.3 | 78.4 | 45.2 | 168 | -229 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 34.1 | 73.6 | 39.9 | 161 | -287 |
Provision for Income Taxes | |||||
Net Income After Taxes | 34.1 | 73.6 | 39.9 | 162 | -288 |
Net Income Before Extraordinary Items | |||||
Net Income | 34.1 | 73.6 | 39.9 | 162 | -288 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 34.1 | 73.6 | 39.9 | 162 | -288 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.125 | 0.151 | 0.072 | 0.228 | -0.183 |
Dividends per Share |